Notice of Proposed Sale · 144
Moderna, Inc.
MRNANASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Moderna, Inc.
- Issuer CIK
- 0001682852
- SEC file number
- 001-38753
- Phone
- 6177146500
- Person for whose account securities are to be sold
- Hoge Stephen
- Relationships to issuer
- Officer
- Street
- 325 BINNEY STREET
- City
- CAMBRIDGE
- State / country code
- MA
- Postal code
- 02142
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 53,336 | 3,605,513.60 | 396,786,259 | 07/15/2026 | NASDAQ | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 07/15/2026 | Stock Option Exercise | Issuer | 53,336 | N | 07/15/2026 | Cash |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Stephen Hoge | Common | 05/15/2026 | 53,336 | 2,581,462.40 |
| Stephen Hoge | Common | 06/15/2026 | 53,336 | 2,739,870.32 |
Seller — prior-sale row 1, entry 1
- Name
- Stephen Hoge
- Street
- 325 Binney Street
- City
- Cambridge
- State / country code
- MA
- Postal code
- 02142
Seller — prior-sale row 2, entry 1
- Name
- Stephen Hoge
- Street
- 325 Binney Street
- City
- Cambridge
- State / country code
- MA
- Postal code
- 02142
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 07/15/2026
- Signed
- /s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Stephen Hoge
- Plan adoption dates
- 11/13/2025
Company context
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna’s mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company’s values and mindsets, Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Current securities
Recent company filings
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementNov 16, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsNov 13, 2026
- 10-Q filingNov 6, 2026
- Results of Operations and Financial ConditionNov 6, 2026
- SCHEDULE 13G/A - filed by FMR LLC regarding Moderna, Inc.Nov 5, 2026